Marie Claude Morice

Summary

Affiliation: Institut Cardiovasculaire Paris Sud
Country: France

Publications

  1. ncbi SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Paris, France
    EuroIntervention 8:325-35. 2012
  2. ncbi Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    EuroIntervention 7:670-9. 2011
  3. ncbi Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and C
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, Massy, France
    Circulation 121:2645-53. 2010
  4. ncbi XIENCE V SPIRIT WOMEN clinical trial: characterization of the female population undergoing stent implantation
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, ICPS, 6 avenue du Noyer Lambert, 91300 Massy, France
    Womens Health (Lond Engl) 4:439-43. 2008
  5. ncbi Stenting for small coronary vessels
    Marie-Claude Morice
    L' Institut Cardiovasculaire Paris-Sud, Antony, France
    J Invasive Cardiol 15:377-9. 2003
  6. ncbi What can we expect from quantitative OCT?
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    Catheter Cardiovasc Interv 72:236. 2008
  7. ncbi [Results of the French register of renal stenting: the Esternal study]
    M C Morice
    Institut Cardiovasculaire Paris Sud, Massy
    Arch Mal Coeur Vaiss 100:827-32. 2007
  8. ncbi Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Am Coll Cardiol 50:1299-304. 2007
  9. ncbi Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    JAMA 295:895-904. 2006
  10. ncbi Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study
    Neus Salvatella
    Institut Hospitalier Jacques Cartier, Massy, France
    EuroIntervention 7:689-96. 2011

Detail Information

Publications60

  1. ncbi SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Paris, France
    EuroIntervention 8:325-35. 2012
    ..SPIRIT Women is the first interventional trial dedicated exclusively to women, focusing on symptoms at presentation, referral time to coronary intervention and the safety and performance of the XIENCE V stent...
  2. ncbi Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    EuroIntervention 7:670-9. 2011
    ..The SYNTAX-LE MANS substudy prospectively evaluated 15-month angiographic and clinical outcomes in patients with treated left main (LM) disease...
  3. ncbi Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and C
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, 6 avenue du Noyer Lambert, Massy, France
    Circulation 121:2645-53. 2010
    ....
  4. ncbi XIENCE V SPIRIT WOMEN clinical trial: characterization of the female population undergoing stent implantation
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, ICPS, 6 avenue du Noyer Lambert, 91300 Massy, France
    Womens Health (Lond Engl) 4:439-43. 2008
    ..In total, approximately 2000 female patients, derived from the general interventional cardiology population, will be enrolled from up to 130 sites outside of the USA...
  5. ncbi Stenting for small coronary vessels
    Marie-Claude Morice
    L' Institut Cardiovasculaire Paris-Sud, Antony, France
    J Invasive Cardiol 15:377-9. 2003
  6. ncbi What can we expect from quantitative OCT?
    Marie Claude Morice
    Institut Hospitalier Jacques Cartier, Massy, France
    Catheter Cardiovasc Interv 72:236. 2008
  7. ncbi [Results of the French register of renal stenting: the Esternal study]
    M C Morice
    Institut Cardiovasculaire Paris Sud, Massy
    Arch Mal Coeur Vaiss 100:827-32. 2007
    ..7 +/- 17.1 ml/min vs. 69.2 +/- 160.3. Renal artery stenting in cardiac patients with renal artery stenosis is associated with a very high success rate, with few complications and an improvement in hypertension and renal function...
  8. ncbi Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Am Coll Cardiol 50:1299-304. 2007
    ..This study examined the clinical outcomes at 5 years in RAVEL (A Randomized Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary Revascularization), the first controlled trial of drug-eluting stents...
  9. ncbi Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial
    Marie Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    JAMA 295:895-904. 2006
    ....
  10. ncbi Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study
    Neus Salvatella
    Institut Hospitalier Jacques Cartier, Massy, France
    EuroIntervention 7:689-96. 2011
    ....
  11. ncbi Transfemoral aortic valve implantation new criteria to predict vascular complications
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    JACC Cardiovasc Interv 4:851-8. 2011
    ..This study sought to evaluate the incidence, impact, and predictors of vascular complications in transcatheter aortic valve implantation (TAVI)...
  12. ncbi Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Am Coll Cardiol 59:566-71. 2012
    ..The purpose of this study was to clarify the impact of sex-related differences in transcatheter aortic valve implantation (TAVI) for high-risk patients with severe aortic stenosis...
  13. ncbi Reproducibility and factors influencing the assessment of the SYNTAX score in the left main Xience study
    Philippe Garot
    Hôpital Claude Galien and Institut Jacques Cartier, Institut Cardiovasculaire Paris Sud, Massy and Quincy, France
    Catheter Cardiovasc Interv 80:231-7. 2012
    ..As assessment of SYNTAX score is made by visual estimate of coronary angiography, discrepancies between evaluations by different observers and the impact of observer experience have not yet been evaluated...
  14. ncbi True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    JACC Cardiovasc Interv 5:207-14. 2012
    ..The purpose of this study was to evaluate the incidence of vascular complications and the predictors of Prostar failure for a "true percutaneous approach" in transfemoral transcatheter aortic valve implantation (TAVI)...
  15. ncbi Transradial approach for coronary angioplasty in the setting of acute myocardial infarction: a dual-center registry
    Yves Louvard
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacquer Cartier, 6 avenue du Noyer Lambert, 91300 Massy, France
    Catheter Cardiovasc Interv 55:206-11. 2002
    ....
  16. ncbi Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry
    Beatriz Vaquerizo
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France
    Circulation 119:2349-56. 2009
    ..The objective of this registry was to evaluate the 2-year outcome of elective percutaneous coronary intervention for unprotected LM disease with paclitaxel-eluting stents...
  17. ncbi Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry
    Christian Spaulding
    Cardiology Department, Cochin Hospital, Rene Descartes University, Paris, France
    Eur Heart J 27:1054-60. 2006
    ..Because of the limited access to high PTCA volume centres in some areas, it has been suggested that PTCA could be performed in low-volume centres on AMI patients. Little data exist on the validity of this strategy in modern era PTCA...
  18. ncbi Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2
    Bernard Chevalier
    Institut Cardiovasculaire Paris Sud, Massy Quincy, France
    Circ Cardiovasc Interv 2:188-95. 2009
    ..The newly developed Nobori coronary stent coated with a bioresorbable polymer, polylactic acid, and the antiproliferative agent Biolimus A9 has the potential to reduce restenosis by suppressing neointima formation...
  19. ncbi Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    JACC Cardiovasc Interv 5:1247-56. 2012
    ..The goal of the study was to clarify the impact of post-procedural aortic regurgitation (post-AR) grade 2/4 on clinical outcomes...
  20. ncbi Stenting of bifurcation lesions using the Bestent: a prospective dual-center study
    Francois Gobeil
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 55:427-33. 2002
    ....
  21. ncbi Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation
    Kentaro Hayashida
    Institut Cardiovasculaire Paris Sud, Massy, France
    EuroIntervention 8:546-55. 2012
    ..However, computed tomography (CT) has potential advantages compared to TEE. We sought to assess the impact of CT-guided valve sizing on post-procedural aortic regurgitation (AR)...
  22. ncbi Late or very late stent thrombosis can also occur with bare metal stents
    Andres Rosas Ramos
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 70:229-32. 2007
    ..In the second case, it occurred three years after the stenting procedure in a bare metal stent implanted in the circumflex artery of a patient who had also received two drug-eluting stents in the left anterior descending coronary artery...
  23. ncbi Delayed and recurrent cardiac tamponade following distal coronary perforation of hydrphilic guidewires during coronary intervention
    Federico De Marco
    Cardiologie Interventionelle, Institut Cardiovasculaire Paris Sud ICPS, Massy, France
    J Invasive Cardiol 20:E150-3. 2008
    ..In the second case, tamponade was successfully treated with immediate pericardial drainage, but tamponade recurred several days later...
  24. ncbi A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction
    Christophe Loubeyre
    Institut Cardiovasculaire Paris Sud, Hôpital Claude Galien, Quincy Sous Senart, France
    J Am Coll Cardiol 39:15-21. 2002
    ....
  25. ncbi Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry
    Darren Mylotte
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, 6 Avenue du Noyer Lamber, Massy, France
    EuroIntervention 8:970-81. 2012
    ..Limited long-term data are available to support drug-eluting stent (DES) unprotected left main (LM) intervention. We sought to evaluate long-term outcomes of LM intervention with paclitaxel-eluting stents...
  26. ncbi Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction
    Philippe Garot
    Institut Cardiovasculaire Paris Sud, Centre Hospitalier Claude Galien, 20 Route de Boussy, 91480 Quincy, France
    Circulation 115:1354-62. 2007
    ..Existing data suggest potential beneficial effects of early myocardial reperfusion, but the predictors of survival in these patients remain unknown...
  27. ncbi Use of a deflectable tip catheter to facilitate complex interventions beyond insertion of coronary bypass grafts: three case reports
    Helen Routledge
    Institute Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 70:862-6. 2007
    ..Use of the Venture Catheter, a deflectable tip 3.5F wire control catheter, facilitated successful percutaneous coronary intervention after prolonged, unsuccessful attempts at conventional guidewire passage...
  28. ncbi Duration of balloon inflation for optimal stent deployment: five seconds is not enough
    Thomas Hovasse
    Department of Interventional Cardiology, Institut Hospitalier Jacques Cartier, Massy, France
    Catheter Cardiovasc Interv 81:446-53. 2013
    ..To assess the effect of the duration of stent inflation on stent expansion using digital stent enhancement (DSE)...
  29. ncbi 2-year outcome of patients treated for bifurcation coronary disease with provisional side branch T-stenting using drug-eluting stents
    Helen C Routledge
    ICPS Institut Cardiovasculaire, Paris Sud, Massy, France
    JACC Cardiovasc Interv 1:358-65. 2008
    ....
  30. ncbi Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock
    Philippe Garot
    Institut Cardiovasculaire Paris Sud, Quincy and Massy, France
    EuroIntervention 6:350-5. 2010
    ..Therefore, we hypothesised that statin therapy has an early beneficial effect among patients undergoing PCI for STEMI complicated by cardiogenic shock...
  31. ncbi [Percutaneous aortic valve implantation: results and perspectives]
    Thomas Hovasse
    Hôpital privé Jacques Cartier, Institut Cardiovasculaire Paris Sud, 91300 Massy, France
    Presse Med 40:732-9. 2011
    ..This new approach is clearly here to stay and should soon reach a maturity phase with respect to its indications, the selection of patients and technical aspects...
  32. ncbi Management of cerebrovascular accidents during cardiac catheterization: immediate cerebral angiography versus early neuroimaging strategy
    Federico De Marco
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 70:560-8. 2007
    ..In contrast the use of immediate neuroimaging by means of MRI or CT scan in two cases delayed the implementation of appropriate therapy...
  33. ncbi Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization
    Darren Mylotte
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, and Hopital Claude Galien, Quincy, France
    JACC Cardiovasc Interv 6:115-25. 2013
    ....
  34. ncbi Percutaneous aortic valve replacement: new hope for inoperable and high-risk patients
    Helen C Routledge
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France
    J Invasive Cardiol 19:478-83. 2007
    ..The technique, initial results and the current limitations of the procedure are explained alongside the ongoing trials necessary in order that such therapy may eventually be made widely available...
  35. ncbi Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial
    Philippe Garot
    Institut Cardio vasculaire Paris Sud, Quincy, France
    J Am Coll Cardiol 46:606-12. 2005
    ..The aim of this research was to determine the influence of bifurcation lesions on the outcome of patients undergoing percutaneous coronary intervention (PCI) in the recent era...
  36. ncbi Acute coronary syndromes: direct stent for all?
    Christophe Loubeyre
    Institut Cardiovasculaire Paris Sud, Quincy, France
    J Invasive Cardiol 14:313-4. 2002
  37. ncbi Safety and feasibility of the radial approach for primary angioplasty in acute myocardial infarction during pregnancy
    Gyarsi Lal Sharma
    Institut Cardiovasculaire Paris Sud, Quincy, France
    J Invasive Cardiol 14:359-62. 2002
    ..We present a case of successful primary angioplasty in acute myocardial infarction during pregnancy via the transradial approach without complications. The patient had an uncomplicated recovery with normal left ventricular function...
  38. ncbi Noncoronary transradial angioplasty with coronary equipment: a less invasive technique
    G L Sharma
    Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacquer Cartier, 6 avenue du Noyer Lambert, 91300 Massy, France
    Catheter Cardiovasc Interv 55:197-205. 2002
    ..With the miniaturization of equipment and improvements in technique, this approach will also become an excellent alternative for noncoronary interventions...
  39. ncbi Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial
    Patrick W Serruys
    Thoraxcentre, Rotterdam, The Netherlands
    Circulation 106:798-803. 2002
    ..The goal of this intravascular ultrasound investigation was to provide a more detailed morphological analysis of the local biological effects of the implantation of a sirolimus-eluting stent compared with an uncoated stent...
  40. ncbi Triple vessel stenting for triple vessel coronary disease
    Beatriz Villegas
    Institut Cardiovasculaire Paris Sud, 6 avenue du Noyer Lambert, 91300, Massy, France
    J Invasive Cardiol 14:1-5. 2002
    ..Most eligible patients underwent uncomplicated and immediately successful procedures. The long-term outcome was comparable to controlled studies of CABG, except for a higher rate of repeat revascularization procedures due to restenosis...
  41. ncbi Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction
    Simon R Dixon
    Division of Cardiology, William Beaumont Hospital, 3601 West 13 Mile Road, Royal Oak, MI 48073, USA
    Am J Cardiol 91:1454-7, A6. 2003
  42. ncbi Successful angioplasty of tripolar renal arteries in a single setting: a case report
    Gyarsi Lal Sharma
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Invasive Cardiol 14:457-60. 2002
    ..PTRA combined with stenting is associated with good immediate and long-term results. This case report describes successful angioplasty of bilateral multiple renal arteries in a single setting with good immediate and follow-up results...
  43. ncbi A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
    Marie-Claude Morice
    Institut Cardiovasculaire Paris Sud, Massy, France
    N Engl J Med 346:1773-80. 2002
    ..CONCLUSIONS: As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events...
  44. ncbi Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility study
    Sigmund Silber
    Internistische Klinik Dr Müller, Herzkatheterlabor Cardiology Associates, Munich, Germany
    J Interv Cardiol 16:491-7. 2003
    ..No other MACE were observed during the three-month follow-up period. Based on the findings of this study, direct stenting with the EXPRESS Stent appears feasible and is well tolerated...
  45. ncbi Comparison of 5 French versus 6 French guiding catheters for transradial coronary intervention: a prospective, randomized study
    Francois Gobeil
    Notre Dame Hospital, Cardiology Department, Montreal University School of Medicine, 1560 Sherbrooke East Street, H2L 4M1, Montreal, Quebec, Canada
    J Invasive Cardiol 16:353-5. 2004
    ..9%; p = 0.05) because of a small radial artery. Transradial intervention using 5 Fr guiding catheters necessitates crossover to a 6 Fr catheter in 6.8% of cases, and offers no clear advantages over the 6 Fr technique...
  46. ncbi The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase
    Andrew T L Ong
    Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Am Heart J 151:1194-204. 2006
    ..Results of the run-in phase were used by the steering committee to determine eligibility and to project enrollment for each site...
  47. ncbi Cause of death with bare metal and sirolimus-eluting stents
    David R Holmes
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Heart J 27:2815-22. 2006
    ..There was no significant difference in either the frequency or the cause of death with implantation of either sirolimus-eluting or bare metal stents...
  48. ncbi Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 356:998-1008. 2007
    ..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
  49. ncbi Percutaneous coronary intervention for bifurcation coronary disease
    Yves Louvard
    Institut Cardiovasculaire Paris Sud, Massy, France
    Heart 90:713-22. 2004
  50. ncbi The NUGGET study: NIR ultra gold-gilded equivalency trial
    Nicolaus Reifart
    Main Taunus Heart Institute, Bad Soden, Germany
    Catheter Cardiovasc Interv 62:18-25. 2004
    ..e., higher neointimal hyperplasia in spite of a significantly better initial gain), with higher restenosis and similar MACE rates at 6 months...
  51. ncbi Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial
    Jean Fajadet
    Clinique Pasteur, 45, Avenue du Lombez, 31300 Toulouse, France
    Circulation 111:1040-4. 2005
    ..This analysis examined whether these beneficial effects persist over the longer term...
  52. ncbi Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis
    Muzaffer Degertekin
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 108:2747-50. 2003
    ..CONCLUSIONS: Vessel dimensions and area of ISA did not change over time, except for 1 coronary aneurysm that became apparent. ISA after implantation of a SES was not associated with adverse events at late follow-up...
  53. ncbi Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial
    Alexandre Abizaid
    Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
    Eur Heart J 25:107-12. 2004
    ..007). Conclusion Diabetics treated with SES were associated with a virtual abolition of neointimal proliferation and low event rates at long-term follow-up...
  54. ncbi Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents
    Eugenia Nikolsky
    Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Catheter Cardiovasc Interv 71:896-906. 2008
    ..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...
  55. ncbi Gender-specific outcomes after sirolimus-eluting stent implantation
    Emilia Solinas
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 50:2111-6. 2007
    ..We examined the impact of gender on outcomes of patients undergoing percutaneous coronary intervention using sirolimus-eluting stents (SES)...
  56. ncbi Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT)
    Remo Albiero
    Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:943-9. 2004
    ..e., percutaneous transluminal coronary angioplasty [PTCA]) for the treatment of patients with coronary in-stent restenosis (ISR)...
  57. ncbi Collateral coronary circulation in the absence of obstructive coronary artery disease
    Rajpal Abhaichand
    Institut Cardiovasculaire Paris Sud, Massy, France
    J Invasive Cardiol 14:331-3. 2002
    ..We believe that this vessel is of congenital origin and after reviewing the literature we describe the angiographic features that distinguish such a vessel from collaterals that are secondary to coronary stenosis or hypoxia...
  58. ncbi Stent supported angioplasty for coronary arterial stenosis following the arterial switch operation
    Rajpal Abhaichand
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 56:278-80. 2002
    ..We could not find a similar report in the literature...
  59. ncbi Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
    Stephan Windecker
    Department of Cardiology, and CTU Bern, Bern University Hospital, Bern, Switzerland
    Lancet 372:1163-73. 2008
    ..We compared the safety and efficacy of a biolimus-eluting stent (with biodegradable polymer) with a sirolimus-eluting stent (with durable polymer)...
  60. ncbi Less invasive PTCA of a gastroepiploic artery combining the transradial approach and 5 Fr guiding catheter: a case report
    Gyarsi Lal Sharma
    Institut Cardiovasculaire Paris Sud, Massy, France
    Catheter Cardiovasc Interv 56:494-7. 2002
    ..In the case presented here, a gastroepiploic graft stenosis was treated by balloon angioplasty performed through a less invasive approach combining transradial access and use of 5 Fr guiding catheter...